Adrenomedullin (1-12), human |
|||
A1001-10 | ApexBio | 10 mg | EUR 137 |
Description: Adrenomedullin (AM) (1-12), human (C64H100N22O19S1), is a peptide with the sequence Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg. It was first discovered to be associated with pheochromocytoma, a tumor arising from adrenal medulla, in 1993. |
Apexbio Reagents Laboratories manufactures the a1006 apexbio reagents distributed by Genprice. The A1006 Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other A1006 products are available in stock. Specificity: A1006 Category: Apexbio
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 1 mg | EUR 113 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 10 mg | EUR 369 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 25 mg | EUR 496 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 5 mg | EUR 241 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Beta-Sheet Breaker Peptide iA?5 |
||
ApexBio | 10 mg | EUR 137 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. |
Beta-Sheet Breaker Peptide iA?5 |
||
ApexBio | 25 mg | EUR 171 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. |
Beta-Sheet Breaker Peptide iA?5 |
||
ApexBio | 5 mg | EUR 102 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. |
ZJ 43 |
|||
A4415-10 | ApexBio | 10 mg | EUR 519 |
Description: IC50: 2.4 nMZJ-43 is a N-acetylaspartylglutamate (NAAG) peptidase inhibitor. The peptide neurotransmitter N-acetylaspartylglutamate (NAAG) is reported to act as an agonist at group II metabotropic glutamate receptors. |
AZ 10417808 |
|||
A4416-5 | ApexBio | 5 mg | EUR 383 |
Description: AZ 10417808 is a selective caspase-3 inhibitor with IC50 value of 14.9 uM [1].The caspase-3 protein is a member of the cysteine-aspartic acid protease (caspase) family. |
Ivachtin |
|||
A4417-1 | ApexBio | 1 mg | EUR 113 |
Description: Ivachtin is a potent inhibitor of caspase-3 with IC50 value of 23 nM [1]. Caspase-3 is a member of the cysteine-aspartic acid protease family and interacts with caspase-8 and caspase-9. Sequential activation of caspases plays an important role in cell apoptosis. |
Ivachtin |
|||
A4417-10 | ApexBio | 10 mg | EUR 370 |
Description: Ivachtin is a potent inhibitor of caspase-3 with IC50 value of 23 nM [1]. Caspase-3 is a member of the cysteine-aspartic acid protease family and interacts with caspase-8 and caspase-9. Sequential activation of caspases plays an important role in cell apoptosis. |
Ivachtin |
|||
A4417-5 | ApexBio | 5 mg | EUR 241 |
Description: Ivachtin is a potent inhibitor of caspase-3 with IC50 value of 23 nM [1]. Caspase-3 is a member of the cysteine-aspartic acid protease family and interacts with caspase-8 and caspase-9. Sequential activation of caspases plays an important role in cell apoptosis. |
Ac-IEPD-AFC |
|||
A4418-5 | ApexBio | 5 mg | EUR 324 |
Description: Peptide sequence shown to be preferred recognition motif for the serine protease granzyme B. Fluorogenic substrate. |
Ac-LEHD-AFC |
|||
A4419-10 | ApexBio | 10 mg | EUR 355 |
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC. |
Ac-LEHD-AFC |
|||
A4419-5 | ApexBio | 5 mg | EUR 216 |
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC. |
PETCM |
|||
A4420-50 | ApexBio | 50 mg | EUR 383 |
Description: PETCM is an activator of caspase-3 [1]. Caspase-3 is a member of the cysteine-aspartic acid protease family and interacts with caspase-8 and caspase-9. Sequential activation of caspases plays an important role in cell apoptosis. |
L 006235 |
|||
A4422-10 | ApexBio | 10 mg | EUR 421 |
Description: IC50: 0.25 nML-006235 is a potent and selective inhibitor of Cathepsin K.In vitro: After dilution of L-006235 to 0.05 nM, the cathepsin K enzyme activity was initially inhibited. |
L 006235 |
|||
A4422-50 | ApexBio | 50 mg | EUR 1617 |
Description: IC50: 0.25 nML-006235 is a potent and selective inhibitor of Cathepsin K.In vitro: After dilution of L-006235 to 0.05 nM, the cathepsin K enzyme activity was initially inhibited. |
SID 26681509 |
|||
A4424-10 | ApexBio | 10 mg | EUR 399 |
Description: IC50: 56 nMSID 26681509 is a potent and reversible human cathepsin L inhibitor.The cathepsins have been found to comprise a family of lysosomal protease enzymes whose primary functions, such as protein degradation, play a keyl role in normal cellular homeostasis. |
SID 26681509 |
|||
A4424-50 | ApexBio | 50 mg | EUR 1520 |
Description: IC50: 56 nMSID 26681509 is a potent and reversible human cathepsin L inhibitor.The cathepsins have been found to comprise a family of lysosomal protease enzymes whose primary functions, such as protein degradation, play a keyl role in normal cellular homeostasis. |
DPPI 1c hydrochloride |
|||
A4425-1 | ApexBio | 1 mg | EUR 226 |
Description: Inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50 = 104 nM) that displays selectivity over enzymes with DPP-like activity (IC50 > 30 ?M). Increases plasma GLP-1 levels and improves glucose tolerance in diabetic mice following oral glucose challenge. |
DPPI 1c hydrochloride |
|||
A4425-10 | ApexBio | 10 mg | EUR 431 |
Description: Inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50 = 104 nM) that displays selectivity over enzymes with DPP-like activity (IC50 > 30 ?M). Increases plasma GLP-1 levels and improves glucose tolerance in diabetic mice following oral glucose challenge. |
K 579 |
|||
A4426-10 | ApexBio | 10 mg | EUR 431 |
Description: Dipeptidyl peptidase IV inhibitor. Inhibits rat, canine, human and monkey enzymes with IC50 values of 3, 5, 8, and 8 nM respectively. Long-acting hypoglycemic agent; attenuates glucose excursion following glucose loading in Zucker fatty rats. |
K 579 |
|||
A4426-50 | ApexBio | 50 mg | EUR 1656 |
Description: Dipeptidyl peptidase IV inhibitor. Inhibits rat, canine, human and monkey enzymes with IC50 values of 3, 5, 8, and 8 nM respectively. Long-acting hypoglycemic agent; attenuates glucose excursion following glucose loading in Zucker fatty rats. |